|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nico B, Benagiano V, Mangieri D, Maruotti
N, Vacca A and Ribatti D: Evaluation of microvascular density in
tumors: Pro and contra. Histol Histopathol. 23:601–607.
2008.PubMed/NCBI
|
|
3
|
Torres C, Wang H, Turner J, Shahsafaei A
and Odze RD: Prognostic significance and effect of
chemoradiotherapy on microvessel density (angiogenesis) in
esophageal Barrett's esophagus-associated adenocarcinoma and
squamous cell carcinoma. Hum Pathol. 30:753–758. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Möbius C, Demuth C, Aigner T, Wiedmann M,
Wittekind C, Mössner J, Hauss J and Witzigmann H: Evaluation of
VEGF A expression and microvascular density as prognostic factors
in extrahepatic cholangiocarcinoma. Eur J Surg Oncol. 33:1025–1029.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kleespies A, Guba M, Jauch KW and Bruns
CJ: Vascular endothelial growth factor in esophageal cancer. J Surg
Oncol. 87:95–104. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tamura M, Gu J, Matsumoto K, Aota S,
Parsons R and Yamada KM: Inhibition of cell migration, spreading
and focal adhesions by tumor suppressor PTEN. Science.
280:1614–1617. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Simpson L and Parsons R: PTEN: Life as a
tumor suppressor. Exp Cell Res. 264:29–41. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dahia PL: PTEN, a unique tumor suppressor
gene. Endocr Relat Cancer. 7:115–129. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chu EC and Tarnawski AS: PTEN regulatory
functions in tumor suppression and cell biology. Med Sci Monit.
10:RA235–RA241. 2004.PubMed/NCBI
|
|
10
|
Chang D, Wang TY, Li HC, Wei JC and Song
JX: Prognostic significance of PTEN expression in esophageal
squamous cell carcinoma from Linzhou City, a high incidence area of
northern China. Dis Esophagus. 20:491–496. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Petersen I: The new WHO classification and
recent results in soft tissue tumor pathology. Pathologe.
34:436–448. 2013.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Blood CH and Zetter BR: Tumor interactions
with the vasculature: Angiogenesis and tumor metastasis. Biochim
Biophys Acta. 1032:89–118. 1990.PubMed/NCBI
|
|
13
|
Weidner N: Chapter 14. Measuring
intratumoral microvessel density. Methods Enzymol. 444:305–323.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weidner N: Intratumor microvessel density
as a prognostic factor in cancer. Am J Pathol. 147:9–19.
1995.PubMed/NCBI
|
|
15
|
Sundov Z, Tomic S, Alfirevic S, Sundov A,
Capkun V, Nincevic Z, Nincevic J, Kunac N, Kontic M, Poljak N, et
al: Prognostic value of MVD, LVD and vascular invasion in lymph
node-negative colon cancer. Hepatogastroenterology. 60:432–438.
2013.PubMed/NCBI
|
|
16
|
Hoeben A, Landuyt B, Highley MS, Wildiers
H, Van Oosterom AT and De Bruijn EA: Vascular endothelial growth
factor and angiogenesis. Pharmacol Rev. 56:549–580. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanaka T, Ishiguro H, Kuwabara Y, Kimura
M, Mitsui A, Katada T, Shiozaki M, Naganawa Y, Fujii Y and Takeyama
H: Vascular endothelial growth factor C (VEGF-C) in esophageal
cancer correlates with lymph node metastasis and poor patient
prognosis. J Exp Clin Cancer Res. 29:832010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kozlowski M, Naumnik W, Niklinski J,
Milewski R, Dziegielewski P and Laudanski J: Vascular endothelial
growth factor C and D expression correlates with lymph node
metastasis and poor prognosis in patients with resected esophageal
cancer. Neoplasma. 58:311–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okazawa T, Yoshida T, Shirai Y, Shiraishi
R, Harada T, Sakaida I, Abe T and Oka M: Expression of vascular
endothelial growth factor C is a prognostic indicator in esophageal
cancer. Hepatogastroenterology. 55:1503–1508. 2008.PubMed/NCBI
|
|
20
|
Chen M, Cai E, Huang J, Yu P and Li K:
Prognostic value of vascular endothelial growth factor expression
in patients with esophageal cancer: A systematic review and
meta-analysis. Cancer Epidemiol Biomarkers Prev. 21:1126–1134.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim KJ, Li B, Winer J, Armanini M, Gillett
N, Phillips HS and Ferrara N: Inhibition of vascular endothelial
growth factor-induced angiogenesis suppresses tumour growth in
vivo. Nature. 362:841–844. 1993. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Banneau G, Guedj M, MacGrogan G, de
Mascarel I, Velasco V, Schiappa R, Bonadona V, David A, Dugast C,
Gilbert-Dussardier B, et al: Molecular apocrine differentiation is
a common feature of breast cancer in patients with germline PTEN
mutations. Breast Cancer Res. 12:R632010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Haier J and Nicolson GL: PTEN regulates
tumor cell adhesion of colon carcinoma cells under dynamic
conditions of fluid flow. Oncogene. 21:1450–1460. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng HC, Li YL, Sun JM, Yang XF, Li XH,
Jiang WG, Zhang YC and Xin Y: Growth, invasion, metastasis,
differentiation, angiogenesis and apoptosis of gastric cancer
regulated by expression of PTEN encoding products. World J
Gastroenterol. 9:1662–1666. 2003.PubMed/NCBI
|
|
25
|
Lu TL, Huang YF, You LR, Chao NC, Su FY,
Chang JL and Chen CM: Conditionally ablated Pten in prostate basal
cells promotes basal-to-luminal differentiation and causes invasive
prostate cancer in mice. Am J Pathol. 182:975–991. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan QF, Li WT, Dong HC, Chen YZ, Yin L,
Liu W, Wang WW, Liu D, Li SG, Gu WY, et al: PTEN hypermethylation
profiles of Chinese Kazakh patients with esophageal squamous cell
carcinoma. Dis Esophagus. 27:396–402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang BH, Zheng JZ, Aoki M and Vogt PK:
Phosphatidylinositol 3-kinase signaling mediates angiogenesis and
expression of vascular endothelial growth factor in endothelial
cells. Proc Natl Acad Sci USA. 97:1749–1753. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vanhaesebroeck B, Stephens L and Hawkins
P: PI3K signalling: The path to discovery and understanding. Nat
Rev Mol Cell Biol. 13:195–203. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou YJ, Xiong YX, Wu XT, Shi D, Fan W,
Zhou T, Li YC and Huang X: Inactivation of PTEN is associated with
increased angiogenesis and VEGF overexpression in gastric cancer.
World J Gastroenterol. 10:3225–3229. 2004.PubMed/NCBI
|
